ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission

January 23, 1981

DCCP Board Gives Concept Approval to Noncompeting Contracts

June 17, 1983

NINDS Awards Grants For Brain Tumor Centers

December 11, 1992

Senior Biomedical Service Proposed To Increase Pay

April 1, 1988

Pressure Grows On Upton To Reveal Plans

November 23, 1979

NCI CTEP Approved Trials For the Month of February

February 22, 2013